Cargando…
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
BACKGROUND: The pandemic of the new type of corona virus infection 2019 [Covid-19] also affect people with Multiple Sclerosis (pwMS). Currently, the accumulating information on the effects of the infection regarding the demographic and clinical characteristics of the disease, as well as outcomes wit...
Autores principales: | Sen, S., Karabudak, R., Schiavetti, I., Demir, S., Ozakbas, S., Tutuncu, M., Petek Balci, B., Turan, O.F., Uzunkopru, C., Koseoglu, M., Yetkin, M.F., Gunduz, T., Gumus, H., Kale Icen, N., Carmisciano, L., Terzi, M., Acar, P., Gungor Dogan, I., Baba, C., Tuncer, A., Uygunoglu, U., Sormani, M.P., Efendi, H., Siva, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053402/ https://www.ncbi.nlm.nih.gov/pubmed/33940495 http://dx.doi.org/10.1016/j.msard.2021.102968 |
Ejemplares similares
-
mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?
por: Tütüncü, Melih, et al.
Publicado: (2023) -
The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
por: Sen, Sedat, et al.
Publicado: (2022) -
Lung involvement correlates with disability in MS patients with COVID-19 pneumonia
por: Immovilli, Paolo, et al.
Publicado: (2022) -
Narrative review based on fingolimod therapy in pediatric MS
por: Piri Cinar, Bilge, et al.
Publicado: (2023) -
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
por: Schiavetti, Irene, et al.
Publicado: (2022)